Abstract:The hydrophilic polymer PEG and its related derivatives, have served as therapeutic agents to reconstruct the phospholipid bilayers of damaged cell membranes by erasing defects in the plasmalemma. The special attributes of hydrophilic polymers when in contact with cell membranes have been used for several decades since these well-known properties have been exploited in the manufacture of monoclonal antibodies. However, while traditional therapeutic efforts to combat traumatic injuries of the central nervous system (CNS) have not been successful, nanotechnology-based drug delivery has become a new emerging strategy with the additional promise of targeted membrane repair. As such, this potential use of nanotechnology provides new avenues for nanomedicine that uses nanoparticles themselves as the therapeutic agent in addition to their other functionalities. Here we will specifically address new advances in experimental treatment of Spinal Cord and Traumatic Brain injury (SCI and TBI respectively). We focus on the concept of repair of the neurolemma and axolemma in the acute stage of injury, with less emphasis on the worthwhile, and voluminous, issues concerning regenerative medicine/nanomedicine. It is not that the two are mutually exclusive - they are not. However, the survival of the neuron and the tissues of white matter are critical to any further success in what will likely be a multi-component therapy for TBI and SCI. This review includes a brief explanation of the characteristics of traumatic spinal cord injury SCI, the biological basis of the injuries, and the treatment opportunities of current polymer-based therapies. In particular, we update our own progress in such applications for CNS injuries with various suggestions and discussion, primarily nanocarrier-based drug delivery systems. The application of nanoparticles as drug-delivery vehicles to the CNS may likely be advantageous over existing molecular-based therapies. As a "proof-of-concept", we will discuss the recent investigations that have preferentially facilitated repair and functional recovery from breaches in neural membranes via rapid sealing and reassembly of the compromised site with silica or chitosan nanoparticles.

Nanoparticle targeting strategies for traumatic brain injury

Biomimetic Nanoparticles as a Theranostic Tool for Traumatic Brain Injury

Nanoparticle‐Based Therapeutics for Brain Injury

Targeting of nanoparticles to the cerebral vasculature after traumatic brain injury

Nanotechnology-driven therapies for neurodegenerative diseases: a comprehensive review

Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands

Utilizing Multifaceted Approaches to Target Drug Delivery in the Brain: From Nanoparticles to Biological Therapies

Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine

Recent Progress of Drug Nanoformulations Targeting to Brain

Nanocarrier-mediated siRNA delivery: a new approach for the treatment of traumatic brain injury-related Alzheimer's disease

Progress and Perspectives on Targeting Nanoparticles for Brain Drug Delivery

Brain-targeted nanoparticle drug delivery systems:research advances

Polymer and nano-technology applications for repair and reconstruction of the central nervous system

The Role of Nanotechnology in Understanding the Pathophysiology of Traumatic Brain Injury

Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair

Multifunctional Nanoparticles and Nanoclusters as a Theranostics and Symptoms Disappearing Agent for Traumatic Brain Injury

Blood–Brain Barrier-Targeting Nanoparticles: Biomaterial Properties and Biomedical Applications in Translational Neuroscience

Advancements in neurotherapeutics: nanoparticles overcoming the blood–brain barrier for precise CNS targeting

Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system

Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases

Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties